Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 5,174 | 4,529 | 5,508 | 4,474 | 823 |
| Gross Profit | 5,174 | 4,529 | 5,508 | 4,474 | 823 |
| Operating Expenses | 47,610 | 45,419 | 42,454 | 28,296 | 22,410 |
| Operating Income | -42,436 | -40,890 | -36,946 | -23,822 | -21,587 |
| Interest Expense | 10,742 | 2,626 | 0 | 64 | 628 |
| Other Income | 34,262 | -25,529 | 29 | 731 | 34 |
| Pre-tax Income | -18,916 | -69,045 | -36,917 | -23,155 | -22,181 |
| Net Income Continuous | -18,916 | -69,045 | -36,917 | -23,155 | -22,181 |
| Net Income | $-18,916 | $-69,045 | $-36,917 | $-23,155 | $-22,181 |
| EPS Basic Total Ops | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 |
| EPS Basic Continuous Ops | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 |
| EPS Diluted Total Ops | -0.89 | -1.91 | -1.08 | -0.96 | -1.35 |
| EPS Diluted Continuous Ops | -0.32 | -1.91 | -1.08 | -0.96 | -1.35 |
| EPS Diluted Before Non-Recurring Items | -1.29 | -1.91 | -1.08 | -0.96 | -1.35 |
| EBITDA(a) | $-41,111 | $-39,918 | $-36,054 | $-22,653 | $-20,473 |